Afuco™ Anti-Human IFNG ADCC Recombinant Antibody (NI-0501), ADCC Enhanced (CAT#: AFC-365CL)

Anti-IFNG ADCC Enhanced Antibody (NI-0501) is an ADCC enhanced antibody produced by our Afuco™ platform. NI-0501 is a fully human monoclonal antibody that neutralizes interferon gamma, a cell-signaling protein believed to play a pivotal role in the development of HLH. In the ongoing Phase II study, NI-0501 was initially administered to patients showing unsatisfactory response or intolerance to conventional therapies including chemotherapy, immune-suppressive medicines, and immune-depleting drugs. The approved amendment to the protocol allows NI-0501 to be administered to patients as a first-line treatment before any other intervention.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA

Figure 1 NI-0501 treatment significantly improved parameters of HLH disease activity.

Figure 1 NI-0501 treatment significantly improved parameters of HLH disease activity.

Allen, C., De Benedetti, F., Grom, A. A., Ballabio, M., Ferlin, W. G., De Min, C., & NI-0501-04 Study Group. (2015). A novel targeted approach to the treatment of hemophagocytic lymphohistiocytosis (HLH) with an anti-interferon gamma (IFNγ) monoclonal antibody (mAb), NI-0501: first results from a pilot phase 2 study in children with primary HLH.

Figure 2 CXCL9 levels tightly correlated with IFNγ production, estimated by measuring IFNγ bound to NI-0501.

Figure 2 CXCL9 levels tightly correlated with IFNγ production, estimated by measuring IFNγ bound to NI-0501.

Allen, C., De Benedetti, F., Grom, A. A., Ballabio, M., Ferlin, W. G., De Min, C., & NI-0501-04 Study Group. (2015). A novel targeted approach to the treatment of hemophagocytic lymphohistiocytosis (HLH) with an anti-interferon gamma (IFNγ) monoclonal antibody (mAb), NI-0501: first results from a pilot phase 2 study in children with primary HLH.


Specifications

  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Autoimmune Diseases; Inflammatory Diseases

Product Property

  • Purity
  • >98% by SDS-PAGE and HPLC analysis
  • Storage
  • 4°C or -20°C, avoid repeated freezing and thawing.

Target

  • Alternative Names
  • IFNG; interferon, gamma; IFG; IFI; interferon gamma; IFN-gamma; immune interferon

Related Resources

  • Related Diseases

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "IFNG"

Humanized Antibody

Mouse Antibody

CAT Product Name Application Type
MOB-0289MC Recombinant Anti-Canine IFN-gamma Antibody. WB, ELISA

Epitope-Specific Antibody

CAT Product Name Application Type
EPAF-0882LC Mouse Anti-IFNG Recombinant Antibody (clone MIF3009) ELISA Mouse IgG1

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-041 Afuco™ Anti-IFNG ADCC Recombinant Antibody (Fontolizumab), ADCC Enhanced IP, IF, FuncS, FC, Neut, ELISA ADCC enhanced antibody
AFC-TAB-423CQ Afuco™ Anti-IFNG ADCC Recombinant Antibody (Emapalumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, FuncS ADCC enhanced antibody

Recombinant Antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-365CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare